Biologic Markers of Angiogenesis: Circulating Endothelial Cells in Patients with Advanced Malignancies Treated on Phase I Protocol with Metronomic Chemotherapy and Celecoxib

By Twardowski Przemyslaw   Smith-Powell Leslie   Carroll Mary   VanBalgooy J.   Ruel Christopher   Frankel Paul   Synold Timothy  

Cancer Investigation, Vol. 26, Iss. 1, 2007-12 ,pp. : 53-59

Informa Healthcare

Access to resources Recommend Favorite

Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy

By Reardon David   Desjardins Annick   Peters Katherine   Gururangan Sridharan   Sampson John   Rich Jeremy   McLendon Roger   Herndon James   Marcello Jennifer   Threatt Stevie   Friedman Allan   Vredenburgh James   Friedman Henry  

Journal of Neuro-Oncology, Vol. 103, Iss. 2, 2011-06 ,pp. : 371-379

Springer Publishing Company

Access to resources Recommend Favorite

Association between mobilization of circulating endothelial progenitor cells and time or degree of injury from angioplasty in patients with exertional angina: A prospective study

By            

Experimental and Therapeutic Medicine, Vol. 10, Iss. 2, 2015-01 ,pp. : 809-815

Spandidos Publications

Access to resources Recommend Favorite

Efficacy of schedule-dependent metronomic S-1 chemotherapy in human oral squamous cell carcinoma cells

By          

International Journal of Oncology, Vol. 43, Iss. 1, 2013-01 ,pp. : 271-279

Spandidos Publications

Access to resources Recommend Favorite

Phase I study of bevacizumab combined with irinotecan and S-1 as second-line chemotherapy in patients with advanced colorectal cancer

By Kusaba Hitoshi   Esaki Taito   Kishimoto Junji   Uchino Keita   Arita Shuji   Kumagai Hozumi   Mitsugi Kenji   Akashi Koichi   Baba Eishi  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 29-34

Springer Publishing Company

Access to resources Recommend Favorite